The 11-13+6 Week Scan Theoretical Course June 1st, 2008, Vancouver Canada
Available as a pre-conference workshop at the ISPD - 14th International
Conference on
Prenatal Diagnosis and Therapy
Online Registration:
http://www.ispdhome.org/conference/2008/registration.asp
Description:
Official Fetal Medicine Foundation certificate course in the 11-13+6 Week Scan.
Objectives:
-
To review the current status of non-invasive genetic screening for chromosome
abnormalities.
-
To ensure that those who perform the 11-13+6 week scan have received the
appropriate training to do so.
-
To ensure that high standards of performance are maintained through continuing
education and audit.
Audience:
Sonographers, sonologists including physicians who perform nuchal translucency
ultrasound.
Course Content:
-
The principles of presnatal genetic screening and diagnosis.
-
The role of the 11-13+6 week scan in the prenatal diagnosis of chromosome and
other abnormalities.
-
Combined screening using ultrasound and maternal biochemistry.
-
The guidelines for the measurement of NT.
-
Practical Demonstration.
Course Credentials:
Once successful, you will receive a certificate to acknowledge successful
completion of the theoretical training of the in the "11-13
+6 Week
Scan Course".
Upon completion of the theoretical course, you will be eligible to register for
the NT Practical Training course (Step 2 of NT credentialing, not included in
this Theory course).
After attendance of the theoretical course and successful completion of the NT
Practical Training course, the physician/sonographer will be sent the
Certificate of Competence in the 11-13+6 weeks scan. In addition,
Physicians/sonographers will be eligible to submit a registration form to the
FMF for the use of the risk calculation and Quality Assurance software.
Course Directors:
Jo-Ann Johnson, MD
Division of Maternal Fetal Medicine
Department of OB/GYN
University of Calgary
Calgary, AB
Confirmed Speakers:
Jon Hyett, MD
Maternal Fetal Medicine
Royal Brisbane and Women's Hospital
Obstetrics and Gynaecology
University of Queensland
Jiri Sonek, M.D., RDMS
Dept of OB/GYN, Wright State University
Dayton, OH and Fetal Medicine Foundation USA
Cathy Downing, RDMS
Fetal Medicine Foundation USA
Preliminary Program:
| 8:00 |
Registration and Coffee |
| 9:00 |
Welcome and Overview |
| 9:10 |
Screening for Chromosomal Defects: An Overview |
| 9:30 |
Screening for Chromosomal Defects at 11-13+6 weeks
- Risk by maternal age and gestation
- Risk by NT thickness
- Risk by other 1st Trimester ultrasound markers
|
| 10:00 |
Break |
| 10:15 |
Combined Screening: Ultrasound & Biochemistry
- First trimester combined screening
- First trimester sequential screening
- Second trimester serum biochemistry
- New biochemical markers: What is on the horizon?
|
| 11:00 |
Second trimester ultrasound markers: The Canadian Guidelines |
| 11:15 |
Methods of obtaining the Karyotype |
| 11:30 |
Putting it all together. What do the new guidelines mean for prenatal screening in Canada? |
| 12:00 |
Lunch (On your own) |
| 1:00 |
Abnormal biochemistry Normal Karyotype |
| 1:15 |
Increased NT and a Normal Karyotype |
| 1:30 |
Early Fetal Anomaly Scan |
| 1:45 |
Multiple Pregnancies: Chorionicity and its Consequences-Screening in Twins |
| 2:00 |
Practical Issues in NT Scanning |
| 2:30 |
Certification process |
| 2:45 |
Multiple choice examination |
| 3:00 |
Break |
| 3:15 |
Practical Demonstration |
| 3:45 |
Q & A |
For further information, please email
info@mfmedicine.com